The POLG germline variant identified in our study is reported as pathogenic in mitochondrial disease cohorts by multiple submitters in ClinVar [16], and somatic variants in POLG are reported in 1% (10/902) of soft tissue tumors in COMIC, of which 30% (3/10) are GISTs [20]. This evidence concerns the gene POLG and soft tissue neoplasm.